ACA vs MLM: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

MLM is the larger of the two ($37.01B market cap): the incumbent the market prices for continued execution (29.01x forward earnings, beta 1.03). ACA is the smaller challenger ($7.32B), priced similarly on forward earnings (30.35x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

ACA vs MLM: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricACAMLMWhat it tells you
Market cap$7.32B$37.01BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E30.3529.01Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E36.8338.84Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta1.081.03Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range100% of range23% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book2.452.10How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how ACA and MLM affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACA and MLM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACA and MLM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Arcosa (ACA) do?

Arcosa was spun out of Trinity Industries in late 2018 and has spent the years since reshaping itself from a diversified industrial into an infrastructure materials company. It now reports two segments. Construction Products sells aggregates, specialty materials such as recycled asphalt and lightweight aggregate, and construction site support, and generated roughly $357.0 million of revenue in the second quarter of 2026. Engineered Structures builds utility poles and steel structures, wind towers, telecom and traffic structures, and storage tanks, and generated roughly $301.7 million. The portfolio pruning has been aggressive: the steel components business went in 2025, and the barge business was sold on April 1, 2026 for approximately $450 million, producing a pre-tax gain of roughly $359.7 million and moving barge results into discontinued operations. On the other side of the ledger, the roughly $1.2 billion Stavola acquisition in late 2024 added asphalt and aggregates positions in the New York and New Jersey metro market.

Full ACA guide

What does Martin Marietta Materials (MLM) do?

Martin Marietta Materials is the second-largest construction aggregates producer in the United States, behind Vulcan Materials. The aggregates business model is identical to Vulcan: heavy aggregates products with high transport costs create local pricing power within each quarry's service area. Martin Marietta operates hundreds of aggregates facilities across the US with concentration in Texas, Colorado, the Carolinas and other high-growth states, and 2026 added quarries in Virginia, Missouri, Kansas, British Columbia, Minnesota and along the I-70 corridor.

Full MLM guide

ACA vs MLM: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • ACA drivers: The CRH merger sets the price; Aggregates pricing over volume.
  • MLM drivers: Federal infrastructure tailwind; Lime and specialty minerals through Lhoist North America.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The largest risk is deal failure. For MLM, construction cycle volatility.

ACA or MLM: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACA if you believe its drivers more; MLM if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACA and MLM guides.

ACA vs MLM: the full fundamentals

ACA. Operating multiples matter less than usual here because the CRH offer sets the price: at $147.01 the stock sits about 2% below the $150 cash consideration, a spread that pays holders for waiting until the expected first-quarter 2027 close and for the risk the deal breaks. Fiscal 2025 remains the cleanest reference point for the business itself, with revenue of roughly $2.88 billion and EPS of about $4.24, since 2026 results include the barge gain. The dividend is nominal at $0.20 a share a year (declared again in September), a yield near 0.14 percent, and full-year guidance stays withdrawn.

MLM. Martin Marietta trades at about 32.5x trailing and 23x forward earnings, a premium that has compressed as the shares fell about 21% this year while 2026 earnings are expected to dip about 9% before rebounding about 25% in 2027 with Lhoist included. The 24 covering analysts hold a buy consensus with a mean target near $634, though most have trimmed targets since late September.

Headline figures (approximate, October 2026): ACA shows revenue (ttm) ~$2.9B, q2 2026 revenue (continuing ops) ~$658.7M, up ~2% year over year, q2 2026 adjusted ebitda ~$145.9M, ~22.1% margin, q2 2026 adjusted eps ~$1.13 vs ~$1.18 estimate; MLM shows revenue (ttm) ~$6.7 billion; Q2 2026 revenue up 21% year over year to a record ~$1.95 billion, operating margin ~20%, eps (ttm) ~$15.42; forward ~$21.90, p/e ~32.5x trailing, ~23x forward.

The bottom line: ACA vs MLM

ACA and MLM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACA and MLM exposure against your real portfolio. It is not an investment adviser.

Wondering how ACA or MLM fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Arcosa

Ask Walnut's AI anything about ACA and see how it fits what you own.

FAQ

What is the difference between ACA and MLM?

+

Arcosa was spun out of Trinity Industries in late 2018 and has spent the years since reshaping itself from a diversified industrial into an infrastructure materials company. Martin Marietta Materials is the second-largest construction aggregates producer in the United States, behind Vulcan Materials. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ACA or MLM the better stock?

+

Neither is universally better. MLM is the larger incumbent; ACA is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ACA or MLM?

+

On forward P/E (as of November 2026), ACA trades at 30.35x and MLM at 29.01x, so MLM is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ACA and MLM?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ACA vs MLM?

+

ACA: The largest risk is deal failure. If the CRH transaction does not close, whether through antitrust review of overlapping aggregates positions or a financing or regulatory delay past the expected first-quarter 2027 close, the share price would no longer be supported by the $150 offer and could revert toward where it traded before June 2026, well under the current level (the 52-week low is about $91). The stockholder vote is no longer a hurdle after the September 4, 2026 approval. Plaintiffs' firms including Monteverde & Associates have publicized investigations of the merger process; those have been solicitations rather than a filed securities-fraud complaint, but merger-related disclosure suits are common and can add noise. Underlying business risks remain: heavy exposure to Texas and Southwest construction weather and cycles, wind tower demand that depends on federal incentives and utility procurement, and leverage carried since the roughly $1.2 billion Stavola acquisition. Trailing earnings are also distorted by the roughly $359.7 million pre-tax barge gain, so headline trailing figures overstate or muddle ongoing profitability. MLM: Construction cycle volatility. Energy costs affect operating margins. Integration risk from four deals in under a year, and much higher debt (about $6.3 billion before the $7 billion Lhoist cash payment was fully reflected). Purchase accounting dents reported margins: aggregates gross profit per ton fell 17% in the second quarter, partly from a $52 million acquired-inventory charge. Lime ties part of the business to steel and industrial cycles. Reserve permitting is increasingly difficult. Analysts cut price targets through September and October 2026 (RBC to $530, Truist to $625, Citigroup to $610), and the stock trades about 30% below its 52-week high of $711.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ACA or MLM; figures are approximate and dated (as of November 2026). Verify current data before investing.